CNTA.D

Centessa Pharmaceuticals plc

Biotechnology · Biotechnology

$112.55 sample

+1.00 (+0.90%) 1D

Market cap

$517.4B

Price as of

2026-10-24

Latest filing

8-K · 2026-10-07

Alerts

8

Price$112.55 -4.70% 3M daily closessample

125.64111.55

2026-07-282026-08-192026-09-102026-10-012026-10-23

purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first

Oct 13INSInsider buy: EVP, Operations
Oct 07SECDEF 14A filed
Oct 02INSInsider sell: Chief Financial Officer
Sep 29INSInsider sell: Director
Sep 21INSInsider sell: Chief Financial Officer
Sep 10INSInsider sell: EVP, Operations
Sep 07INSInsider sell: Chief Executive Officer
Aug 31SEC10-Q filed

Sign up to see the real CNTA.D record →

Company facts

SEC EDGAR registration

Name: Centessa Pharmaceuticals plc
Sector: Biotechnology
Industry: Biotechnology
Smart-money score: +53sample, -100 to +100
Reporting currency: USD

Who is positioning in CNTA.D

sample

Insiders: 29 insider transactions over 90 days, net selling, $817.9M
Congress: 1 members traded over 90 days
Institutions · 13F: 15 funds hold $12.5B
Activists · 13D/G: No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end

Revenue$33.4B +22.0% y/y

Q4 2024Q3 2026

Inventory$19.6B +8.0% y/y

Q4 2024Q3 2026

Accounts receivable$14.9B +8.1% y/y

Q4 2024Q3 2026

Total debt$39.3B +13.6% y/y

Q4 2024Q3 2026

Peers

sample

Sample peer A: $479.0B +6.4% 3M
Sample peer B: $172.6B -8.7% 3M
Sample peer C: $233.8B +6.4% 3M
Sample peer D: $293.8B +1.5% 3M
Sample peer E: $304.8B +11.7% 3M